# AgomAb (AGMB) — Analyst Forecast

AGMB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/agmb/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 8 | 0 | 0 | 8 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 25, 2026 | Piper Sandler | Initiated Coverage | Overweight | $60.00 |
| Aug 19, 2026 | Cantor Fitzgerald | Initiated Coverage | Overweight | — |
| Jul 23, 2026 | B. Riley Securities | Initiated Coverage | Buy | $34.00 |
| Jun 22, 2026 | HC Wainwright & Co. | Initiated Coverage | Buy | $35.00 |
| Mar 3, 2026 | Morgan Stanley | Initiated Coverage | Overweight | $28.00 |
| Mar 3, 2026 | Leerink Partners | Initiated Coverage | Outperform | $36.00 |
| Mar 3, 2026 | JP Morgan | Initiated Coverage | Overweight | $32.00 |

## Frequently Asked Questions

### Is AGMB a buy, sell, or hold?

Analysts covering AgomAb currently average a Buy rating: 8 buy, 0 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on AGMB?

On Aug 25, 2026, Piper Sandler initiated coverage of AgomAb at Overweight with a price target of $60.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).